Procainamide-induced agranulocytosis with reversible myeloid sensitivity
✍ Scribed by John C. Nelson; John D. Lutton; Arthur E. Fass
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 440 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
✦ Synopsis
A 56-year-old man developed procainamide-induced agranulocytosis. Bone marrow aspiration showed the absence of myeloid elements beyond the promyelocyte stage. Procainamide at therapeutic concentrations in vitro depressed bone marrow granulocyte-macrophage colonies (CFUc) while CFUc growth was normal in the absence of drug. Following the patient's recovery, CFUc growth was no longer suppressed by procainamide in vitro. The observations in this patient showing reversible sensitivity to drug contrast with those on other patients with drug-induced agranulocytosis that show persistent marrow injury or drug sensitivity despite clinical recovery.